157 related articles for article (PubMed ID: 16481384)
21. Economic evaluation of three two-drug chemotherapy regimens in advanced non-small-cell lung cancer.
Neymark N; Lianes P; Smit EF; van Meerbeeck JP
Pharmacoeconomics; 2005; 23(11):1155-66. PubMed ID: 16277550
[TBL] [Abstract][Full Text] [Related]
22. Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesine.
Vansteenkiste JF; Vandebroek JE; Nackaerts KL; Weynants P; Valcke YJ; Verresen DA; Devogelaere RC; Marien SA; Humblet YP; Dams NL;
Ann Oncol; 2001 Sep; 12(9):1221-30. PubMed ID: 11697832
[TBL] [Abstract][Full Text] [Related]
23. Cost analysis of hospital treatment--two chemotherapic regimens for non-surgical non-small cell lung cancer. GFPC (Groupe Français Pneumo Cancérologie).
Vergnenègre A; Perol M; Pham E
Lung Cancer; 1996 Feb; 14(1):31-44. PubMed ID: 8696719
[TBL] [Abstract][Full Text] [Related]
24. Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer.
Martoni A; Marino A; Sperandi F; Giaquinta S; Di Fabio F; Melotti B; Guaraldi M; Palomba G; Preti P; Petralia A; Artioli F; Picece V; Farris A; Mantovani L
Eur J Cancer; 2005 Jan; 41(1):81-92. PubMed ID: 15617993
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of chemotherapy for nonsmall-cell lung cancer.
Dranitsaris G; Cottrell W; Evans WK
Curr Opin Oncol; 2002 Jul; 14(4):375-83. PubMed ID: 12130919
[TBL] [Abstract][Full Text] [Related]
26. Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review.
Clegg A; Scott DA; Hewitson P; Sidhu M; Waugh N
Thorax; 2002 Jan; 57(1):20-8. PubMed ID: 11809985
[TBL] [Abstract][Full Text] [Related]
27. Influence of cisplatin-use, age, performance status and duration of chemotherapy on symptom control in advanced non-small cell lung cancer: detailed symptom analysis of a randomised study comparing cisplatin-vindesine to gemcitabine.
Vansteenkiste J; Vandebroek J; Nackaerts K; Dooms C; Galdermans D; Bosquée L; Delobbe A; Deschepper K; Van Kerckhoven W; Vandeurzen K; Deman R; D'Odemont JP; Siemons L; Van den Brande P; Dams N;
Lung Cancer; 2003 May; 40(2):191-9. PubMed ID: 12711121
[TBL] [Abstract][Full Text] [Related]
28. Economic evaluation in a randomized phase III clinical trial comparing gemcitabine/cisplatin and etoposide/cisplatin in non-small cell lung cancer.
Sacristán JA; Kennedy-Martin T; Rosell R; Cardenal F; Antón A; Lomas M; Alberola V; Massuti B; Carrato A; Minshall M
Lung Cancer; 2000 May; 28(2):97-107. PubMed ID: 10717327
[TBL] [Abstract][Full Text] [Related]
29. A Cost-Effectiveness Analysis of Gemcitabine plus Cisplatin Versus Gemcitabine Alone for Treatment of Advanced Biliary Tract Cancer in Japan.
Tsukiyama I; Ejiri M; Yamamoto Y; Nakao H; Yoneda M; Matsuura K; Arakawa I; Saito H; Inoue T
J Gastrointest Cancer; 2017 Dec; 48(4):326-332. PubMed ID: 27785685
[TBL] [Abstract][Full Text] [Related]
30. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
[TBL] [Abstract][Full Text] [Related]
31. Cost-Utility Analysis of First-Line Pemetrexed Plus Cisplatin in Non-Small Cell Lung Cancer in Thailand.
Permsuwan U; Thongprasert S; Sirichanchuen B
Value Health Reg Issues; 2020 May; 21():9-16. PubMed ID: 31634796
[TBL] [Abstract][Full Text] [Related]
32. Estimation of the additional costs of chemotherapy for patients with advanced non-small cell lung cancer.
Maslove L; Gower N; Spiro S; Rudd R; Stephens R; West P
Thorax; 2005 Jul; 60(7):564-9. PubMed ID: 15994264
[TBL] [Abstract][Full Text] [Related]
33. Healthcare outcomes: gemcitabine cost-effectiveness in the treatment of non-small cell lung cancer.
Szczepura A
Lung Cancer; 2002 Nov; 38 Suppl 2():S21-8. PubMed ID: 12431825
[TBL] [Abstract][Full Text] [Related]
34. The cost-effectiveness of four cisplatin-containing chemotherapy regimens in the treatment of stages III B and IV non-small cell lung cancer: an Italian perspective.
Palmer AJ; Brandt A
Monaldi Arch Chest Dis; 1996 Aug; 51(4):279-88. PubMed ID: 8909011
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness analysis of bevacizumab versus pemetrexed for advanced non-squamous NSCLC in Italy.
Giuliani G; Grossi F; de Marinis F; Walzer S
Lung Cancer; 2010 Aug; 69 Suppl 1():S11-7. PubMed ID: 20727457
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: an estimate using the Population Health Model lung cancer module.
Evans WK
Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-56-S7-63. PubMed ID: 9194482
[TBL] [Abstract][Full Text] [Related]
37. Cost effectiveness of treatment with new agents in advanced non-small-cell lung cancer: a systematic review.
Bongers ML; Coupé VM; Jansma EP; Smit EF; Uyl-de Groot CA
Pharmacoeconomics; 2012 Jan; 30(1):17-34. PubMed ID: 22201521
[TBL] [Abstract][Full Text] [Related]
38. Cost-Effectiveness and Value of Information of Erlotinib, Afatinib, and Cisplatin-Pemetrexed for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer in the United States.
Ting J; Tien Ho P; Xiang P; Sugay A; Abdel-Sattar M; Wilson L
Value Health; 2015 Sep; 18(6):774-82. PubMed ID: 26409604
[TBL] [Abstract][Full Text] [Related]
39. Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in Europe.
Schiller J; Tilden D; Aristides M; Lees M; Kielhorn A; Maniadakis N; Bhalla S
Lung Cancer; 2004 Jan; 43(1):101-12. PubMed ID: 14698544
[TBL] [Abstract][Full Text] [Related]
40. Gemcitabine. A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer.
Noble S; Goa KL
Drugs; 1997 Sep; 54(3):447-72. PubMed ID: 9279506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
